Crossmark

Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection

Crossref DOI link: https://doi.org/10.1186/s12885-021-07894-6

Published Online: 2021-02-19

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yuan, Yan

Xiao, Wei-Wei

Xie, Wei-Hao

Cai, Pei-Qiang

Wang, Qiao-Xuan

Chang, Hui

Chen, Bao-Qing

Zhou, Wen-Hao

Zeng, Zhi-Fan

Wu, Xiao-Jun

Liu, Qing

Li, Li-Ren

Zhang, Rong

Gao, Yuan-Hong
License Information

Text and Data Mining valid from 2021-02-19

Version of Record valid from 2021-02-19
More Information

Article History

Received: 17 December 2020

Accepted: 5 February 2021

First Online: 19 February 2021

Ethics approval and consent to participate

: This observational study was performed in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of Sun Yat-sen University Cancer Center (B2020–063-01). All patients have signed the informed consent form before treatment.

: Not applicable.

: The authors report no conflicts of interest.

Document is current

Any future updates will be listed below